ClinicalTrials.Veeva

Menu

TransForm™ Occlusion Balloon Catheter Registry

Stryker logo

Stryker

Status

Completed

Conditions

Intracranial Aneurysms

Treatments

Device: TransForm™ Occlusion Balloon Catheter

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The primary objective of this registry is to collect real world data on the safety and performance of the TransForm™ Occlusion Balloon Catheter when used in current neurointerventional procedures

Full description

  • This is a prospective, single-arm, non-randomized, multi-center, observational registry.
  • The expected duration for study enrollment is approximately 6 months-1 year.
  • Study participation for each subject will be completed upon removal of the guide catheter post-procedure.
  • Up to 140 subjects will be enrolled at up to 15 study sites. A given site will be allowed to enroll a maximum of 20 subjects.
  • Enrollment in the registry occurs after a signed Informed Consent Form has been obtained, and the index procedure starts.

Enrollment

81 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject or legal representative is willing and has provided informed consent.
  2. Subject is scheduled to undergo a neurointerventional procedure that may include the use of the occlusion balloon catheter.
  3. Subject is over 18 years of age.

Exclusion criteria

  1. Subject's anatomy precludes safe delivery of the TransForm Occlusion Balloon Catheter.
  2. Subject's pregnant

Trial design

81 participants in 1 patient group

TransForm™ Occlusion Balloon Catheter
Description:
TransForm™ Occlusion Balloon Catheter
Treatment:
Device: TransForm™ Occlusion Balloon Catheter

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems